NOVARTIS PHARMA LLC,   

Eye drops 1%.

Solution for infusions 5 mg / 100 ml.

The coated tablets are 25 mg.

The coated tablets are 25 mg.

Tablets of 2.5 mg.

The film-coated tablets are 200 mg and 400 mg.

Tablets, 50 mg.

Capsules, 0.5 mg.

Tablets, 10 mg.

Concentrate for the preparation of a solution for infusions of 4 mg / 5 ml.

Solution for infusion 4 mg / 100 ml.

Solution for intravenous and intramuscular injection, 2 mg / ml.

Lyophilizate for the preparation of a solution for subcutaneous administration, 150 mg.

Tablets, film-coated, 80 mg + 12.5 mg, 160 mg + 12.5 mg, 160 mg + 25 mg, 320 mg + 12.5 mg and 320 mg + 25 mg.

Lyophilizate for the preparation of a solution for subcutaneous administration, 150 mg, complete with a solvent - water for injection.

Lyophilizate for the preparation of a solution for infusions, 350 mg and 500 mg.

Solution for intraocular administration with ranibizumab 10 mg / ml.

1. To 0.23 ml in a bottle of colorless glass, corked with a rubber stopper, coated with an aluminum cap with a snap-off lid.

By one a vial complete with a needle equipped with a filter to extract the contents from the vial, a syringe, an injection needle along with an instruction for medical application in a cardboard box.

1. For 0.165 ml of the drug in pre-filled glass syringe, sealed with a rubber stopper with a white polypropylene cover to control the first opening. One by one in advance filled syringe in a blister equipped with a label, along with instructions for medical use in a cardboard box.

Eye drops 0.5%; 1%.

Capsules with powder for inhalation, 150 mcg and 300 mcg.

Lyophilizate for the preparation of a solution for subcutaneous and intravenous administration of 18 million IU / ml in a vial.

Film-coated tablets, 25 mg and 50 mg.

Concentrate for the preparation of a solution for infusions of 50 mg / ml, 1 ml in ampoules.

Microspheres for suspension for intramuscular administration, 10 mg, 20 mg and 30 mg.

Solution for subcutaneous administration 0.3 mg / ml, 0.6 mg / ml and 0.9 mg / ml.

1 ml each in ampoules from colorless glass, the ampoule has a broken point. 6

ampoules are placed into the paper with instructions for use in

cardboard tutu.

Multi-pack. 3, 5 or 10 packs of 6 ampoules.

Drops of the eye 0.5 mg + 0.4 mg / ml.

Tablets coated with 60 mg, 120 mg, 180 mg

12 tablets in a blister pack. 1, 2, 5, 7, 10 or 30 blisters with instructions for use in a cardboard bundle.

Film-coated tablets, 40 mg, 80 mg or 160 mg.

A set of capsules and film-coated tablets, 50 mg and 0.5 mg, 50 mg and 2.0 mg, 75 mg and 0.5 mg, 75 mg and 2.0 mg.

Syrup 100 mg / 5 ml 100 ml in a vial of dark glass with a screw cap provided with a stopper.

Tablets 200 mg, 400 mg.

Tablets of prolonged action, coated with a coating, 200 mg and 400 mg.

Tablets, film-coated, 150 mg, 300 mg, 600 mg.

Suspension for oral administration, 60 mg / ml.

Capsules with powder for inhalation 50 μg + 110 μg.

Tablets coated with a coating, 125 mg, 250 mg, 500 mg.

Capsules, 10 mg, 15 mg and 20 mg.

Capsule with powder for inhalation set.

Tablets of prolonged action, film-coated, 7.5 mg and 15 mg.

Film-coated tablets, 50 mg (25.7 mg + 24.3 mg); 100 mg (51.4 mg + 48.6 mg); 200 mg (102.8 mg + 97.2 mg).